Spravato® for Depression Treatment in Manhattan
Spravato® nasal spray is the groundbreaking FDA-approved medication for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions.
Introducing Spravato® Esketamine Therapy in Manhattan
Good Health Psychiatry Clinic in Manhattan is a leader in progressive mental health solutions. We are pleased to make available Spravato®, the first FDA-approved nasal spray created for the treatment of adults experiencing TRD and depressive symptoms associated with Major Depressive Disorder (MDD) that includes suicidal thoughts or behaviors.
For Manhattan residents who haven’t achieved sufficient relief with standard antidepressant treatments, Spravato® represents a beacon of hope. This treatment offers a chance for substantial improvement in mental health wellness.
Spravato® is applied through a nasal spray, ensuring quick entry into the bloodstream. Its key component, esketamine, is designed to interact with mood-related neurotransmitters in the brain. The quick-acting delivery system aims to provide faster relief than traditional oral antidepressants, a significant benefit for those who need rapid results.
Benefits of Spravato® Esketamine Spray in Manhattan
Rapid Reduction in Symptoms
Experience swift symptom relief, with some individuals noting changes in just days.
High Efficacy
A fresh approach that has demonstrated success in addressing TRD and MDD with suicidal tendencies.
Safety
A straightforward, non-invasive nasal spray given under professional oversight ensures a safe treatment experience.
Spravato® Treatment Process at Manhattan's Good Health Clinic
The therapy process begins with a detailed consultation by our expert healthcare staff. We evaluate your health history, current psychological state, and treatment objectives. This comprehensive review helps us ascertain whether Spravato® is a suitable option for you.
Our team in Manhattan crafts a customized treatment plan to cater to your unique needs, aiming to optimize the therapeutic outcomes. The plan includes considerations for the depth of your depression, prior treatments, and existing health conditions to ensure a safe and effective therapy.
During your Spravato® treatment phase, you will receive extensive clinical support and oversight from our committed healthcare team. Our professionals are dedicated to offering careful monitoring and responsive care throughout the therapy period. We are always on hand to resolve any queries or concerns, helping you feel confident and supported on your treatment journey.
Testimonials
Monitoring for Safety and Potential Side Effects
Due to the possible side effects like sedation and dissociation, we monitor patients closely for a minimum of two hours following each Spravato® administration. This protocol is part of the Spravato® Risk Evaluation and Mitigation Strategy (REMS), enforced strictly at our Manhattan facility to maintain patient safety.
Important adverse effects to watch for include sedation, dissociation, elevated blood pressure, and occasionally, respiratory depression. Manhattanites with a history of substance abuse or particular cardiovascular conditions should discuss these risks with their healthcare provider. We place a high priority on closely observing mood and behavioral changes, particularly regarding suicidal thoughts.
Spravato® is not suitable for everyone. Patients must undergo a comprehensive assessment to determine eligibility. Close follow-up care is vital to track progress and response to the treatment.
Insurance we accept
At Good Health, we understand that accessing quality psychiatric, psychotherapy services is essential for your well-being. As a leading psychiatrist in Brooklyn, NY, we’re committed to providing you with the care you need, and we work diligently to make it as accessible as possible. We accept a wide range of insurance plans to cover our comprehensive psychiatry services, including Aetna, Oscar, HIP insurance, and more. Our dedicated team is here to help you navigate the complexities of insurance coverage, making the process as smooth as possible. Please don’t hesitate to reach out to us with any questions or concerns about your insurance coverage. Your mental health is our priority, and we’re here to support you on your journey to good health.
Expectations Following Treatment in Manhattan
Patients treated with Spravato® should anticipate possible improvements in depressive symptoms as early as two days after the first administration, though individual results can vary.
It’s essential to keep in close contact with your healthcare provider post-treatment, especially if new symptoms appear or if changes in mood, behavior, or thoughts occur. Regular follow-up visits are crucial at Good Health to assess the ongoing effectiveness of the treatment and to decide if further sessions are required.
For those in Manhattan considering Spravato® therapy for depression, reach out to Good Health Psychiatry Clinic to arrange an evaluation. Our skilled team is prepared to assist you through each phase of the process, from initial consultation to sustained care and support.
Schedule an Appointment
Thank you for your interest in Good Health Psychiatric Services P.C. We kindly request that you provide us with the necessary information in the fields below, and one of our representatives will be in touch with you shortly. We appreciate your time and look forward to the opportunity to assist you.
FAQs About Spravato® Esketamine Therapy
Spravato® is an FDA-approved nasal spray treatment containing esketamine, used for adults with TRD and MDD with suicidal thoughts or actions.
Spravato® is self-administered under healthcare professional supervision at certified treatment centers, following REMS guidelines to ensure safety.
Common side effects include dissociation, dizziness, nausea, sedation, increased blood pressure, and in rare cases, respiratory depression.
Adults with MDD who have not had an adequate response to at least two oral antidepressants may be considered for Spravato® treatment.
In clinical trials, Spravato® has shown to reduce depressive symptoms, with some effect seen within two days. Its effectiveness can vary and is part of a comprehensive treatment plan.